Prostate cancer in a transgenic mouse
- PMID: 7724580
- PMCID: PMC42182
- DOI: 10.1073/pnas.92.8.3439
Prostate cancer in a transgenic mouse
Abstract
Progress toward understanding the biology of prostate cancer has been slow due to the few animal research models available to study the spectrum of this uniquely human disease. To develop an animal model for prostate cancer, several lines of transgenic mice were generated by using the prostate-specific rat probasin promoter to derive expression of the simian virus 40 large tumor antigen-coding region. Mice expressing high levels of the transgene display progressive forms of prostatic disease that histologically resemble human prostate cancer, ranging from mild intraepithelial hyperplasia to large multinodular malignant neoplasia. Prostate tumors have been detected specifically in the prostate as early as 10 weeks of age. Immunohistochemical analysis of tumor tissue has demonstrated that dorsolateral prostate-specific secretory proteins were confined to well-differentiated ductal epithelial cells adjacent to, or within, the poorly differentiated tumor mass. Prostate tumors in the mice also display elevated levels of nuclear p53 and a decreased heterogeneous pattern of androgen-receptor expression, as observed in advanced human prostate cancer. The establishment of breeding lines of transgenic mice that reproducibly develop prostate cancer provides an animal model system to study the molecular basis of transformation of normal prostatic cells and the factors influencing the progression to metastatic prostate cancer.
Similar articles
-
Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.J Cell Biochem. 2005 Feb 1;94(2):279-97. doi: 10.1002/jcb.20339. J Cell Biochem. 2005. PMID: 15565647 Review.
-
A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.Cancer Res. 2001 Mar 1;61(5):2239-49. Cancer Res. 2001. PMID: 11280793
-
Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.Lab Invest. 1998 Jun;78(6):i-xv. Lab Invest. 1998. PMID: 9645768
-
Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.Lab Invest. 1998 Mar;78(3):319-33. Lab Invest. 1998. Corrected and republished in: Lab Invest. 1998 Jun;78(6):i-xv.. PMID: 9520945 Corrected and republished.
-
Genetic alterations in the development of mammary and prostate cancer in the C3(1)/Tag transgenic mouse model.Int J Oncol. 1998 Feb;12(2):449-53. Int J Oncol. 1998. PMID: 9458374 Review.
Cited by
-
The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissues.Front Oncol. 2024 Apr 12;14:1392085. doi: 10.3389/fonc.2024.1392085. eCollection 2024. Front Oncol. 2024. PMID: 38680860 Free PMC article.
-
Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer.Cell Death Differ. 2024 Jun;31(6):779-791. doi: 10.1038/s41418-024-01295-5. Epub 2024 Apr 23. Cell Death Differ. 2024. PMID: 38654072
-
Dietary vitamin D is a novel modulator of tumor engraftment through regulation of GC protein abundance.Res Sq [Preprint]. 2024 Feb 16:rs.3.rs-3911213. doi: 10.21203/rs.3.rs-3911213/v1. Res Sq. 2024. PMID: 38410461 Free PMC article. Preprint.
-
The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissues.bioRxiv [Preprint]. 2024 Jan 6:2023.09.27.559832. doi: 10.1101/2023.09.27.559832. bioRxiv. 2024. Update in: Front Oncol. 2024 Apr 12;14:1392085. doi: 10.3389/fonc.2024.1392085. PMID: 38260443 Free PMC article. Updated. Preprint.
-
Biomarkers and experimental models for cancer immunology investigation.MedComm (2020). 2023 Dec 2;4(6):e437. doi: 10.1002/mco2.437. eCollection 2023 Dec. MedComm (2020). 2023. PMID: 38045830 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous